SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Todd Bartkowiak, Michael A. Curran, 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity, Frontiers in Oncology, 2015, 5,

    CrossRef

  2. 2
    Si-Hyeong Lee, Sayyed Nilofar Danishmalik, Jeong-Im Sin, DNA Vaccines, electroporation and their applications in cancer treatment, Human Vaccines & Immunotherapeutics, 2015, 00

    CrossRef

  3. 3
    Stefanie N. Linch, Michael J. McNamara, William L. Redmond, OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal, Frontiers in Oncology, 2015, 5,

    CrossRef

  4. 4
    Manzoor Ahmad Mir, Developing Costimulatory Molecules for Immunotherapy of Diseases, 2015,

    CrossRef

  5. 5
    Adam J. Adler, Anthony T. Vella, Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation, OncoImmunology, 2013, 2, 1, e22837

    CrossRef

  6. 6
    Marie-Clare St. Rose, Roslyn A Taylor, Suman Bandyopadhyay, Harry Z Qui, Adam T Hagymasi, Anthony T Vella, Adam J Adler, CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion, Immunology and Cell Biology, 2013, 91, 2, 173

    CrossRef

  7. 7
    Michiel Kroesen, Dennis Lindau, Peter Hoogerbrugge, Gosse J Adema, Immunocombination therapy for high-risk neuroblastoma, Immunotherapy, 2012, 4, 2, 163

    CrossRef

  8. 8
    Daria Capece, Daniela Verzella, Mariafausta Fischietti, Francesca Zazzeroni, Edoardo Alesse, Targeting Costimulatory Molecules to Improve Antitumor Immunity, Journal of Biomedicine and Biotechnology, 2012, 2012, 1

    CrossRef

  9. 9
    Bridget P. Keenan, Elizabeth M. Jaffee, Whole Cell Vaccines—Past Progress and Future Strategies, Seminars in Oncology, 2012, 39, 3, 276

    CrossRef

  10. 10
    Shannon E. Smith, Dominique B. Hoelzinger, Ana Lucia Dominguez, Jacques Van Snick, Joseph Lustgarten, Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses, Cancer Immunology, Immunotherapy, 2011, 60, 12, 1775

    CrossRef

  11. 11
    Kuang Youlin, Weng Xiaodong, Liu Xiuheng, Zhu Hengchen, Chen Zhiyuan, Jiang Botao, Chen Hui, Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses, Cancer Letters, 2010, 293, 2, 254

    CrossRef

  12. 12
    Juan Dubrot, Aitziber Portero, Gorka Orive, Rosa María Hernández, Asis Palazón, Ana Rouzaut, Jose L. Perez-Gracia, Sandra Hervás-Stubbs, Jose Luis Pedraz, Ignacio Melero, Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells, Cancer Immunology, Immunotherapy, 2010, 59, 11, 1621

    CrossRef

  13. 13
    Duk-Jae Han, David B. Weiner, Jeong-Im Sin, DNA Vaccines against Infectious Diseases and Cancer, Biomolecules and Therapeutics, 2010, 18, 1, 1

    CrossRef

  14. 14
    Xingsheng Wang, Kun Zhou, Liang Huang, Yiqun Yan, Induction of anti-tumor immunity by dendritic cells pulsed with an endoplasmic reticulum retrieval signal modifies heparanase epitope in mice, Cytotherapy, 2010, 12, 6, 735

    CrossRef

  15. 15
    Ana Lucia Dominguez, Joseph Lustgarten, Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses, Vaccine, 2010, 28, 5, 1383

    CrossRef

  16. 16
    Joseph Lustgarten, Cancer, aging and immunotherapy: lessons learned from animal models, Cancer Immunology, Immunotherapy, 2009, 58, 12, 1979

    CrossRef

  17. 17
    Simona Vertuani, Chiara Triulzi, Anna Karin Roos, Jehad Charo, Håkan Norell, François Lemonnier, Pavel Pisa, Barbara Seliger, Rolf Kiessling, HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice, Cancer Immunology, Immunotherapy, 2009, 58, 5, 653

    CrossRef

  18. 18
    Angela D Pardee, Amy K Wesa, Walter J Storkus, Integrating costimulatory agonists to optimize immune-based cancer therapies, Immunotherapy, 2009, 1, 2, 249

    CrossRef

  19. 19
    Michael Croft, The role of TNF superfamily members in T-cell function and diseases, Nature Reviews Immunology, 2009, 9, 4, 271

    CrossRef

  20. 20
    Michael Croft, Takanori So, Wei Duan, Pejman Soroosh, The significance of OX40 and OX40L to T-cell biology and immune disease, Immunological Reviews, 2009, 229, 1
  21. 21
    Limei Ai, Hanyun Ren, Yongjin Shi, Yujun Dong, Enhancement of anti-lymphoma immuno-effects mediated by dendritic cells pulsed with heat-stressed and rituximab-coated CD20+ lymphoma cells, International Journal of Hematology, 2008, 87, 5, 459

    CrossRef

  22. 22
    Eyad Elkord, Robert E Hawkins, Peter L Stern, Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy, Expert Opinion on Biological Therapy, 2008, 8, 4, 385

    CrossRef

  23. 23
    Annalisa Capobianco, Angelo A. Manfredi, Antonella Monno, Patrizia Rovere-Querini, Claudio Rugarli, Melanoma and Lymphoma Rejection Associated With Eosinophil Infiltration Upon Intratumoral Injection of Dendritic and NK/LAK Cells, Journal of Immunotherapy, 2008, 31, 5, 458

    CrossRef

  24. 24
    Simone Mocellin, Donato Nitti, Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines, Medicinal Research Reviews, 2008, 28, 3
  25. 25
    Aihua Song, Jianxun Song, Xiaohong Tang, Michael Croft, Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals, European Journal of Immunology, 2007, 37, 5
  26. 26
    Ignacio Melero, Sandra Hervas-Stubbs, Martin Glennie, Drew M. Pardoll, Lieping Chen, Immunostimulatory monoclonal antibodies for cancer therapy, Nature Reviews Cancer, 2007, 7, 2, 95

    CrossRef

  27. 27
    I O-Sullivan, A Chopra, T S Kim, S Magnuson, M T Falduto, J Huang, E P Cohen, New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice, Cancer Gene Therapy, 2007, 14, 4, 389

    CrossRef

  28. 28
    A Chopra, I O-Sullivan, J Carr, T S Kim, E P Cohen, T-regulatory cells are relatively deficient in squamous carcinomas undergoing regression in mice immunized with a squamous carcinoma vaccine enriched for immunotherapeutic cells, Cancer Gene Therapy, 2007, 14, 6, 573

    CrossRef

  29. 29
    Jennifer Jacob, Olga Radkevich, Guido Forni, John Zielinski, David Shim, Richard F. Jones, Wei-Zen Wei, Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice, Cellular Immunology, 2006, 240, 2, 96

    CrossRef

  30. 30
    Xiaoyan Lin, Chunxia Zhou, Shengdian Wang, Dongmei Wang, Wenbo Ma, Xiao Liang, Chen Lin, Zheng Wang, Jie Li, Sujuan Guo, Youhui Zhang, Shuren Zhang, Enhanced antitumor effect against human telomerase reverse transcriptase (hTERT) by vaccination with chemotactic-hTERT gene-modified tumor cell and the combination with anti-4-1BB monoclonal antibodies, International Journal of Cancer, 2006, 119, 8